160 related articles for article (PubMed ID: 35230260)
1. Controversies about the systematic preoperative pharmacological treatment before pheochromocytoma or paraganglioma surgery.
Castinetti F; De Freminville JB; Guerin C; Cornu E; Sarlon G; Amar L
Eur J Endocrinol; 2022 Mar; 186(5):D17-D24. PubMed ID: 35230260
[TBL] [Abstract][Full Text] [Related]
2. Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.
Yang Y; Zhang J; Fang L; Jia X; Zhang W
Drug Des Devel Ther; 2022; 16():3599-3608. PubMed ID: 36262769
[TBL] [Abstract][Full Text] [Related]
3. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma.
Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936
[TBL] [Abstract][Full Text] [Related]
4. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma.
Berends AMA; Kerstens MN; Lenders JWM; Timmers HJLM
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32726444
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Management of Pheochromocytoma and Paraganglioma.
Fang F; Ding L; He Q; Liu M
Front Endocrinol (Lausanne); 2020; 11():586795. PubMed ID: 33117294
[TBL] [Abstract][Full Text] [Related]
6. The role of pre-operative α-blockade in patients with normotensive phaeochromocytoma or paraganglioma: A retrospective cohort study.
Kong H; Li N; Li XY; Wang DX
Eur J Anaesthesiol; 2018 Nov; 35(11):898-899. PubMed ID: 30278035
[No Abstract] [Full Text] [Related]
7. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Buitenwerf E; Osinga TE; Timmers HJLM; Lenders JWM; Feelders RA; Eekhoff EMW; Haak HR; Corssmit EPM; Bisschop PHLT; Valk GD; Veldman RG; Dullaart RPF; Links TP; Voogd MF; Wietasch GJKG; Kerstens MN
J Clin Endocrinol Metab; 2020 Jul; 105(7):2381-91. PubMed ID: 31714582
[TBL] [Abstract][Full Text] [Related]
8. Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary?
Isaacs M; Lee P
Clin Endocrinol (Oxf); 2017 Mar; 86(3):309-314. PubMed ID: 27864838
[TBL] [Abstract][Full Text] [Related]
9. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
[TBL] [Abstract][Full Text] [Related]
10. Preoperative α-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis.
Wang J; Liu Q; Jiang S; Zhang J; He J; Li Y; Wang D
Int J Surg; 2023 May; 109(5):1470-1480. PubMed ID: 37037514
[TBL] [Abstract][Full Text] [Related]
11. To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.
Van Den Heede K; Paspala A; Chander N; Chidambaram S; Wernig F; Todd JF; DiMarco AN; Palazzo FF
Ann R Coll Surg Engl; 2022 Feb; 104(2):138-143. PubMed ID: 34582296
[TBL] [Abstract][Full Text] [Related]
12. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma and Paraganglioma in Pregnancy: a New Era.
Gruber LM; Young WF; Bancos I
Curr Cardiol Rep; 2021 May; 23(6):60. PubMed ID: 33961120
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients.
Kim JH; Lee HC; Kim SJ; Lee KE; Jung KC
Front Endocrinol (Lausanne); 2022; 13():816833. PubMed ID: 35282440
[TBL] [Abstract][Full Text] [Related]
15. Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients.
Kim JH; Lee HC; Kim SJ; Yoon SB; Kong SH; Yu HW; Chai YJ; Choi JY; Lee KE; Lee KW; Min SK; Shin CS; Park KJ
Sci Rep; 2021 Sep; 11(1):18574. PubMed ID: 34535733
[TBL] [Abstract][Full Text] [Related]
16. Preoperative pharmacological management of phaeochromocytoma.
van der Horst-Schrivers AN; Kerstens MN; Wolffenbuttel BH
Neth J Med; 2006 Sep; 64(8):290-5. PubMed ID: 16990692
[TBL] [Abstract][Full Text] [Related]
17. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment.
Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A
Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma crisis is not a surgical emergency.
Scholten A; Cisco RM; Vriens MR; Cohen JK; Mitmaker EJ; Liu C; Tyrrell JB; Shen WT; Duh QY
J Clin Endocrinol Metab; 2013 Feb; 98(2):581-91. PubMed ID: 23284003
[TBL] [Abstract][Full Text] [Related]
19. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?
Shao Y; Chen R; Shen ZJ; Teng Y; Huang P; Rui WB; Xie X; Zhou WL
J Hypertens; 2011 Dec; 29(12):2429-32. PubMed ID: 22025238
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
